(Q39350883)

11 September 2017

Vector-based miR-15a/16-1 plasmid inhibits colon cancer growth in vivo (English)

1 reference

11 September 2017

1 reference

Lixia Dai

1

1 reference

11 September 2017

Wei Wang

2

1 reference

11 September 2017

Shuang Zhang

3

1 reference

11 September 2017

Qingyuan Jiang

4

1 reference

11 September 2017

Ruibo Wang

5

1 reference

11 September 2017

Lei Dai

6

1 reference

11 September 2017

Lin Cheng

7

1 reference

11 September 2017

Yang Yang

8

1 reference

11 September 2017

Yu-Quan Wei

9

1 reference

11 September 2017

Hong-Xin Deng

10

1 reference

11 September 2017

1 August 2012

1 reference

Cell Biology International

11 September 2017

1 reference

11 September 2017

36

1 reference

11 September 2017

8

1 reference

11 September 2017

765-770

1 reference

MicroRNAs: genomics, biogenesis, mechanism, and function

11 September 2017

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110404

The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110404

MiR-15a and miR-16-1 cluster functions in human leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110404

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110404

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110404

Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110404

miR-15 and miR-16 induce apoptosis by targeting BCL2

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110404

Angiogenesis modulation in cancer research: novel clinical approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110404

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110404

Roles of small RNAs in tumor formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110404

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110404

Estimates of cancer incidence and mortality in Europe in 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110404

MicroRNAs: opening a new vein in angiogenesis research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110404

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110404

Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110404

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110404

21 January 2018

Genomics of microRNA.

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110404

The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110404

The diverse functions of microRNAs in animal development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110404

Targeting microRNA expression to regulate angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110404

DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110404

Prospects of RNA interference therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110404

Morelloflavone, a biflavonoid, inhibits tumor angiogenesis by targeting rho GTPases and extracellular signal-regulated kinase signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110404

The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110404

MicroRNAs: novel regulators in the hallmarks of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110404

Analyzing real-time PCR data by the comparative C(T) method

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110404

Improved DNA: liposome complexes for increased systemic delivery and gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110404

The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110404

microRNAs as oncogenes and tumor suppressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110404

RNA interference-mediated silencing of the phosphatidylinositol 3-kinase catalytic subunit attenuates growth of human ovarian cancer cells in vitroand in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110404

21 January 2018

Identifiers

DOI

10.1042/CBI20110404

1 reference

11 September 2017

1 reference